BB Biotech AG
BION
Rang in Aktien
#4553
BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG.... BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG. This fund allocates capital to publicly traded companies worldwide, with a primary focus on firms pioneering modern biotechnology, specifically in the development of medications and diagnostic tools. The construction of its investment portfolio is guided by a fundamental analysis approach. Established on November 9, 1993, BB Biotech AG is headquartered in Switzerland.
Aktienkurs
$60.31
Marktkapitalisierung
$3.33B
Veränderung (1 Tag)
-1.39%
Veränderung (1 Jahr)
23.25%
Land
CH
Handel BB Biotech AG (BION)
Kategorie
Financial Services
Kursverlauf für BB Biotech AG (BION)
Höchster Schlusskurs: $63.76 am 2026-10-01
Niedrigster Schlusskurs: $15.30 am 2000-01-01
Niedrigster Schlusskurs: $15.30 am 2000-01-01
Kursverlauf der Aktie von BB Biotech AG von 2000 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | 6.35% |
| 2025 | 38.69% |
| 2024 | -11.18% |
| 2023 | -24.95% |
| 2022 | -25.80% |
| 2021 | 2.69% |
| 2020 | 17.40% |
| 2019 | 11.01% |
| 2018 | -6.61% |
| 2017 | 23.80% |
| 2016 | -7.89% |
| 2015 | 22.59% |
| 2014 | 52.76% |
| 2013 | 62.77% |
| 2012 | 49.65% |
| 2011 | 1.37% |
| 2010 | -14.60% |
| 2009 | 29.73% |
| 2008 | -26.26% |
| 2007 | 3.29% |
| 2006 | 23.76% |
| 2005 | 1.84% |
| 2004 | 19.32% |
| 2003 | 21.32% |
| 2002 | -43.88% |
| 2001 | -30.37% |
| 2000 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $1.15K | 1.58% |
US
|
|
| $41.13 | 24.37% |
SE
|
|
| $109.74 | -32.14% |
US
|
|
| $89.85 | -27.13% |
US
|
|
| $46.03 | -14.74% |
US
|
